We are excited to be participating at the 12th mRNA Health Conference 2024, taking place on November 12-14, 2024 in Boston, USA.
With our expanded portfolio of innovative technologies and expertise, we provide comprehensive solutions to accelerate the production of complex therapeutics such as plasmid DNA, RNA-based therapies, and viral-based vaccines. Furthermore, in collaboration with MIT, ReciBioPharm has created the world's first fully integrated, continuous mRNA manufacturing platform (CP), revolutionising and significantly reducing manufacturing costs. CP drastically shortens manufacturing time and product development timelines while increasing product purity and yield.
Every breakthrough, drug candidate, and therapeutic innovation we help develop is driven by a commitment to improving human health. We aim to transform the lives of patients worldwide and drive meaningful impact across the healthcare landscape.
Meet us at the 12th mRNA Health Conference to discover first-hand how we are shaping the future of medicine and empowering healthcare providers with ground-breaking therapies that revolutionise the way we approach drug development.